Not available outside of the UK & Ireland.
Application
Transaminase has been used in a study to assess the effect of ischemic preconditioning on pathophysiologic alterations of hemodynamic, biochemical and inflammatory parameters observed during intra-abdominal hypertension. Transaminase levels have also been used in a study to investigate the use of hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis.
General description
Increased transaminase activity alters the rate at which precursors of protein are interchanged with carbohydrate intermediates.
Packaging
10 mg in poly bottle
Physical form
Lyophilized powder containing potassium phosphate buffer salts
Unit Definition
One unit will produce 1.0 µmole of oxaloacetate from L-aspartate during the transamination of 2-ketoglutarate per min at pH 7.0 at 25 °C in the presence of pyridoxal phosphate.
This product has met the following criteria: